Comparison between the Outcomes of Intracoronary and Intravenous Administration of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Acute ST-Elevation Myocardial Infarction-Reference-Cited by-同舟云学术

Comparison between the Outcomes of Intracoronary and Intravenous Administration of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Acute ST-Elevation Myocardial Infarction

Published:2016 Issue:4 Volume:23 Page:465-476
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Esfandi Amir¹,Fotouhi Mohammad¹,Allami Abbas²,Ebrahimi Morteza¹

Affiliation:

1. Department of Cardiology, Bu-Ali Sina Hospital, Qazvin University of Medical Sciences

2. Department of Infectious Diseases, Bu-Ali Sina Hospital, Qazvin University of Medical Sciences

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/23/4/23_30965/_pdf

Reference46 articles.

1. 1) O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX: 2013 ACCF/AHA Guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 2013; 127: e362-e425

2. 2) Antman EM, Loscalzo J: ST-segment elevation myocardial infarction. In: Longo DL, Fauci AS, editors. Harrison's Principles of Internal Medicine [ebook]. 18th ed. United States of America: McGraw-Hill's Professional Publishing Division; 2012. chap. 245.

3. 3) Lerman A, Holmes DR, Herrmann J, Gersh BJ: Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both? Eur Heart J, 2007; 28: 788-797

4. 4) Popma JJ, Bhatt DL: Percutaneous coronary intervention. In: Bonow RO, Mann DL, editors. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine [ebook]. 9th ed. Philadelphia: Elsevier Saunders; 2012. chap. 58.

5. 6) Marciniak SJ Jr, Mascelli MA, Furman MI, Michelson AD, Jakubowski JA, Jordan RE, Marchese PJ, Frelinger AL: An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates. Thromb Haemost, 2002; 87: 1020-1025

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis;Thrombosis Journal;2023-07-14

2. Reperfusion Strategies in Acute Myocardial Infarction: State of the Art;International Journal of Cardiovascular Sciences;2021-05-26

3. Comparison between Bolus Intracoronary versus Bolus Intravenous Injection Regimens of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Anterior ST-Segment Elevation Myocardial Infarction;Rational Pharmacotherapy in Cardiology;2019-03-03

4. Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study;European Journal of Medical Research;2018-05-18

5. Meta-Analysis of Randomized Trials of Intracoronary Versus Intravenous Glycoprotein IIb/IIIa Inhibitors in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention;The American Journal of Cardiology;2017-10